@article{01GSYS28TQXMHYTKWHPDPRH0AP,
  abstract     = {{Treatment of chronic myeloid leukemia has improved significantly with the introduction of tyrosine kinase inhibitors (TKIs), and treatment guidelines based on numerous clinical trials are available for chronic phase disease. However for CML in the blast phase (CML-BP), prognosis remains poor and treatment options are much more limited. The spectrum of treatment strategies for children and adolescents with CML-BP has largely evolved empirically and includes treatment principles derived from adult CML-BP and pediatric acute leukemia. Given this heterogeneity of treatment approaches, we formed an international panel of pediatric CML experts to develop recommendations for consistent therapy in children and adolescents with this high-risk disease based on the current literature and national standards. Recommendations include detailed information on initial diagnosis and treatment monitoring, differentiation from Philadelphia-positive acute leukemia, subtype-specific selection of induction therapy, and combination with tyrosine kinase inhibitors. Given that allogeneic hematopoietic stem cell transplantation currently remains the primary curative intervention for CML-BP, we also provide recommendations for the timing of transplantation, donor and graft selection, selection of a conditioning regimen and prophylaxis for graft-versus-host disease, post-transplant TKI therapy, and management of molecular relapse. Management according to the treatment recommendations presented here is intended to provide the basis for the design of future prospective clinical trials to improve outcomes for this challenging disease.}},
  author       = {{Sembill, Stephanie and Ampatzidou, Maria and Chaudhury, Sonali and Dworzak, Michael and Kalwak, Krzysztof and Karow, Axel and Kiani, Alexander and Krumbholz, Manuela and Luesink, Maaike and Naumann-Bartsch, Nora and De Moerloose, Barbara and Osborn, Michael and Schultz, Kirk R. and Sedlacek, Petr and Giona, Fiorina and Zwaan, Christian Michel and Shimada, Hiroyuki and Versluijs, Birgitta and Millot, Frederic and Hijiya, Nobuko and Suttorp, Meinolf and Metzler, Markus}},
  issn         = {{0887-6924}},
  journal      = {{LEUKEMIA}},
  keywords     = {{Oncology,Cancer Research,Hematology}},
  language     = {{eng}},
  pages        = {{505--517}},
  publisher    = {{Springer Science and Business Media LLC}},
  title        = {{Management of children and adolescents with chronic myeloid leukemia in blast phase : international pediatric CML expert panel recommendations}},
  url          = {{http://doi.org/10.1038/s41375-023-01822-2}},
  volume       = {{37}},
  year         = {{2023}},
}

Altmetric

View in Altmetric

Web of Science

Times cited: